190 related articles for article (PubMed ID: 31906860)
1. Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation.
Ngwa T; Orman E; Gomez EV; Vuppalanchi R; Kubal C; Chalasani N; Ghabril M
BMC Gastroenterol; 2020 Jan; 20(1):4. PubMed ID: 31906860
[TBL] [Abstract][Full Text] [Related]
2. Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites.
Onali S; Kalafateli M; Majumdar A; Westbrook R; O'Beirne J; Leandro G; Patch D; Tsochatzis EA
Liver Int; 2017 Sep; 37(9):1334-1344. PubMed ID: 28296047
[TBL] [Abstract][Full Text] [Related]
3. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.
Scheiner B; Parada-Rodriguez D; Bucsics T; Schwabl P; Mandorfer M; Pfisterer N; Riedl F; Sieghart W; Ferlitsch A; Trauner M; Peck-Radosavljevic M; Reiberger T
Scand J Gastroenterol; 2017 Sep; 52(9):1008-1015. PubMed ID: 28532189
[TBL] [Abstract][Full Text] [Related]
4. Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients.
Bossen L; Krag A; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Jun; 63(6):1968-76. PubMed ID: 26599983
[TBL] [Abstract][Full Text] [Related]
5. Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Kruzik M; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
Gastroenterology; 2014 Jun; 146(7):1680-90.e1. PubMed ID: 24631577
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites.
Sinha R; Lockman KA; Mallawaarachchi N; Robertson M; Plevris JN; Hayes PC
J Hepatol; 2017 Jul; 67(1):40-46. PubMed ID: 28213164
[TBL] [Abstract][Full Text] [Related]
7. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis.
Sersté T; Njimi H; Degré D; Deltenre P; Schreiber J; Lepida A; Trépo E; Gustot T; Moreno C
Liver Int; 2015 Aug; 35(8):1974-82. PubMed ID: 25611961
[TBL] [Abstract][Full Text] [Related]
8. Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis.
Lai M; Fenton C; Ge J; Rubin J; Lai JC; Cullaro G
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756037
[TBL] [Abstract][Full Text] [Related]
9. Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation.
Leithead JA; Rajoriya N; Tehami N; Hodson J; Gunson BK; Tripathi D; Ferguson JW
Gut; 2015 Jul; 64(7):1111-9. PubMed ID: 25281417
[TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative nonselective beta-blocker use on acute kidney injury after living donor liver transplantation: Propensity score analysis.
Jeong HW; Kim JH; Han SB; Kwon HM; Jun IG; Song JG; Hwang GS
Ann Hepatol; 2024; 29(4):101474. PubMed ID: 38331385
[TBL] [Abstract][Full Text] [Related]
11. Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.
Facciorusso A; Roy S; Livadas S; Fevrier-Paul A; Wekesa C; Kilic ID; Chaurasia AK; Sadeq M; Muscatiello N
Dig Dis Sci; 2018 Jul; 63(7):1737-1746. PubMed ID: 29725793
[TBL] [Abstract][Full Text] [Related]
12. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
Giannelli V; Roux O; Laouénan C; Manchon P; Ausloos F; Bachelet D; Rautou PE; Weiss E; Moreau R; Mebazaa A; Cohen-Solal A; Durand F; Francoz C
J Hepatol; 2020 Mar; 72(3):463-471. PubMed ID: 31622697
[TBL] [Abstract][Full Text] [Related]
13. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates.
Kim SG; Larson JJ; Lee JS; Therneau TM; Kim WR
Liver Transpl; 2017 Jun; 23(6):733-740. PubMed ID: 28187503
[TBL] [Abstract][Full Text] [Related]
14. Non-selective beta-blockers increase overall and liver mortality in alcoholic cirrhosis with MELD ≥ 12 over 5 years of follow-up.
Calès P; Bertrais S; Boursier J; Fouchard I; Oberti F;
Liver Int; 2021 Jan; 41(1):168-179. PubMed ID: 32979020
[TBL] [Abstract][Full Text] [Related]
15. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.
Shukla R; Kramer J; Cao Y; Ying J; Tansel A; Walder A; Advani S; El-Serag HB; Kanwal F
Am J Gastroenterol; 2016 Dec; 111(12):1778-1787. PubMed ID: 27670600
[TBL] [Abstract][Full Text] [Related]
16. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
Sersté T; Melot C; Francoz C; Durand F; Rautou PE; Valla D; Moreau R; Lebrec D
Hepatology; 2010 Sep; 52(3):1017-22. PubMed ID: 20583214
[TBL] [Abstract][Full Text] [Related]
17. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study.
Kang SH; Lee M; Kim MY; Lee JH; Jun BG; Kim TS; Choi DH; Suk KT; Kim YD; Cheon GJ; Kim DJ; Baik SK
Hepatol Int; 2021 Apr; 15(2):424-436. PubMed ID: 33860898
[TBL] [Abstract][Full Text] [Related]
18. Propranolol plus endoscopic ligation for variceal bleeding in patients with significant ascites: Propensity score matching analysis.
Yoo JJ; Kim SG; Kim YS; Lee B; Jeong SW; Jang JY; Lee SH; Kim HS; Jun BG; Kim YD; Cheon GJ
Medicine (Baltimore); 2020 Jan; 99(5):e18913. PubMed ID: 32000397
[TBL] [Abstract][Full Text] [Related]
19. Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
Kim TW; Kim HJ; Chon CU; Won HS; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
Clin Mol Hepatol; 2012 Jun; 18(2):203-12. PubMed ID: 22893871
[TBL] [Abstract][Full Text] [Related]
20. Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis.
Snoga JL; Lusk KA; Attridge RT; Attridge RL
Ann Pharmacother; 2020 Apr; 54(4):322-330. PubMed ID: 31701773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
